Overuse of rescue medication among asthma patients is associated with increased exacerbations and higher total and asthma-related healthcare costs.
Christopher M. Blanchette, PhD
Advertisement
Articles by Christopher M. Blanchette, PhD
Compared with ipratropium alone, fluticasone/salmeterol combination therapy resulted in better clinical outcomes and similar or lower treatment costs in all COPD populations studied.
Advertisement
Latest Updated Articles
- Economic Assessment of Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
Published: July 15th 2008 | Updated:
- Relationship Between Short-Acting β-Adrenergic Agonist Use and Healthcare Costs
Published: January 24th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
2
White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx
3
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
4
Smartphone App Reduces Depression in Adults With Intellectual Disabilities
5
